Harvard Apparatus Regenerative Technology Announces $5 Million Financing to Continue Clinical Trial
August 26, 2024 14:36 ET
|
Harvard Apparatus Regenerative Technology, Inc.
Holliston, MA, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage...
Harvard Apparatus Regenerative Technology Schedules Conference Call and Webcast for Q3 2023 Results
November 09, 2023 14:45 ET
|
Harvard Apparatus Regenerative Technology, Inc.
HOLLISTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“HRGN” or the “Company”), a clinical-stage biotechnology company developing the...